FDA Inspection
Chongqing Daxin Pharmaceutical Co., Ltd.Chongqing Daxin Pharmaceutical Co., Ltd. – FDA Inspection, May 11, 2018
Record Details
This FDA Inspection record concerns Chongqing Daxin Pharmaceutical Co., Ltd., with an inspection on May 11, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · cda74d6b-05ac-44c9-a971-2273e84327b9
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1056109
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Chongqing Daxin Pharmaceutical Co., Ltd.
2| Date | Classification | Office | Project area |
|---|---|---|---|
| June 28, 2024 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 29, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Chongqing Daxin Pharmaceutical Co., Ltd.
- FDA Inspection 1245029 - 2024-06-28
- FDA Inspection 912081 - 2015-01-29
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.